《Journal Of Thoracic Disease》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱胸部疾病雜志,本刊主要出版、報道醫(yī)學-RESPIRATORY SYSTEM領域的研究動態(tài)以及在該領域取得的各方面的經驗和科研成果,介紹該領域有關本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術信息交流,提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄,為該領域相關學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為2.1,最新CiteScore 指數(shù)為4.6。
本刊近期中國學者發(fā)表的論文主要有:
Combination of neutrophil-to-lymphocyte ratio and albumin concentration to predict the prognosis of esophageal squamous cell cancer patients undergoing esophagectomy
C-reactive protein and lactate dehydrogenase serum levels potentially predict the response to checkpoint inhibitors in patients with advanced non-small cell lung cancer
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.